CD84 (SLAMF5) activation upregulates PD-L1 expression on CLL cells and stroma cells, through the AKT/mTOR pathway, and promotes PD-1 expression on T cells resulting in their exhaustion (38). Here, CD84 is linked to B-cell chronic lymphocytic leukemia.